StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories total Company Consolidated Net Sales — Organic / Comparable Sales Growth (%) (%)

Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A

QuarterlyAnnual
Latest, Q3 2026
7.0%
Period ended Sep 30, 2026
Change on a year earlier
+1.5 pts
5.5% in Q3 2025
History
43 quarters
Since Q4 2015
Sources
43
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Company Consolidated Net Sales — Organic / Comparable Sales Growth (%) (%)Year on yearSource
Q3 2026Sep 30, 20267.0%+1.5 ptsSEC Filing (0001628280-26-066601) ↗
Q2 2026Jun 30, 20264.8%-2.1 ptsSEC Filing (0001628280-26-048377) ↗
Q1 2026Mar 31, 20263.7%-3.2 ptsSEC Filing (0001628280-26-025365) ↗
Q4 2025Dec 31, 20253.0%-5.8 ptsSEC Filing (0001628280-26-002982) ↗
Q3 2025Sep 30, 20255.5%-2.1 ptsSEC Filing (0001628280-25-045049) ↗
Q2 2025Jun 30, 20256.9%-0.5 ptsSEC Filing (0001628280-25-035135) ↗
Q1 2025Mar 31, 20256.9%+2.2 ptsSEC Filing (0001628280-25-017924) ↗
Q4 2024Dec 31, 20248.8%+6.7 ptsSEC Filing (0001628280-25-002092) ↗
Q3 2024Sep 30, 20247.6%+9.1 ptsSEC Filing (0001628280-24-042893) ↗
Q2 2024Jun 30, 20247.4%+16.6 ptsSEC Filing (0001628280-24-032182) ↗
Q1 2024Mar 31, 20244.7%–SEC Filing (0001628280-24-016497) ↗
Q4 2023Dec 31, 20232.1%+8.2 ptsSEC Filing (0001628280-24-002009) ↗
Q3 2023Sep 30, 2023-1.5%-2.8 ptsSEC Filing (0001628280-23-034544) ↗
Q2 2023Jun 30, 2023-9.2%-23.5 ptsSEC Filing (0001628280-23-025156) ↗
Q4 2022Dec 31, 2022-6.1%-13.8 ptsSEC Filing (0001628280-23-001516) ↗
Q3 2022Sep 30, 20221.3%-21.1 ptsSEC Filing (0001628280-22-026588) ↗

Cite this data

StockData. (2026). Abbott Laboratories Total Company Consolidated Net Sales — Organic / Comparable Sales Growth (%) (%), quarterly Q4 2015–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/tot-co-yoy-org

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.